Related Experiment Video
Updated: Aug 4, 2025

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Association between Substance Misuse and Outcomes in Critically III Patients with Pneumonia
Paul M Reynolds1,2,3, Majid Afshar4, Garth C Wright1
1University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences.
In intensive care unit (ICU) patients with pneumonia, alcohol misuse increased mortality, while opioid misuse decreased it. Other substance misuse showed varied effects on survival outcomes.
Area of Science:
- Critical Care Medicine
- Public Health
- Pharmacology
Background:
- Alcohol misuse is linked to higher mortality in intensive care unit (ICU) patients with pneumonia.
- The impact of other substance misuse on mortality in this population remains unclear.
Purpose of the Study:
- To investigate the association between alcohol, cannabis, opioid, stimulant misuse, or polysubstance misuse and mortality in ICU patients with pneumonia.
- To examine secondary outcomes such as mechanical ventilation, vasopressor, and paralytic use in relation to substance misuse.
Main Methods:
- Retrospective cohort study using the Premier Healthcare Database (2010-2017).
- Included 167,095 ICU patients diagnosed with pneumonia and treated with antibiotics or antivirals.
- Substance misuse identified via ICD codes; multivariable logistic regression adjusted for confounders.
Main Results:
- Alcohol misuse was associated with increased in-hospital mortality (OR 1.12).
- Opioid misuse was associated with decreased in-hospital mortality (OR 0.46).
- Cannabis, stimulant, and polysubstance misuse showed non-significant associations with mortality after adjustment.
Conclusions:
- Subtypes of substance misuse have differential effects on mortality in severe pneumonia ICU patients.
- Findings highlight the complex relationship between substance use disorders and critical illness outcomes.
- Administrative data offer insights but require careful interpretation due to inherent biases.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

